NCT01310647View on ClinicalTrials.gov

Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

February 28, 2014

Conditions
Ovarian Diseases
Interventions
DRUG

Testosterone

Transdermal testosterone (20µg/kg/day)from day 24 of the previous cycle to day 2 of the ICSI cycle

DRUG

Estradiol

Transdermal estradiol (200µg/day)from day 20 of the previous cycle to day 3 of the ICSI cycle

DRUG

CombEq

"(150µg Desogestrel + 30µg Ethinylestradiol)/day during the luteal phase of the two cycles prior to the ICSI.~Valerate estradiol 4mg/day during 10 days, starting the second day of the cycle prios to the ICSI cycle."

Trial Locations (1)

46026

La Fe University Hospital. Department of Obstetrics and Gynecology, Valencia

All Listed Sponsors
lead

Instituto de Investigacion Sanitaria La Fe

OTHER

NCT01310647 - Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders | Biotech Hunter | Biotech Hunter